Debt / Common Equity for Protalix Biotherapeutics Inc

Join now and get access to the full platform

Search for company or ETF

0 results available. Select is focused ,type to refine list, press Down to open the menu,

PLX: Protalix Biotherapeutics Inc

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based p...

835.00 USD

Price

– USD

Fair Value

–

Upside

394.00 - 899.85

52-week range

Create Chart Create Model Add To Watchlist

Analysis

Fiscal Years

Trailing Twelve Months

Fiscal Halfs

Fiscal Quarters

Daily

Hide this widget

Benchmarks

Hide this widget

No data available

Metric Usage

Hide this widget

No data available

Similar Metrics

Hide this widget

No data available

Search for metric or datapoint

Definition of Debt / Common Equity

Hide this widget

No data available

Sector Benchmark Analysis

Sector

Industry Group

Industry

Hide this widget

No data available